e.halonen
TL2 · Antalya
Contributes reviews on supplier material. Based in Antalya.
Joined 28 October 2024 · last posted 2d
90 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #110 · Outcomes › Progress reports · 25 Jul 2026 · 20 likes I have been on both sides of the seven-day rolling argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
How to ask a question when you cannot say why you are asking it Replied, post #48 · Start Here › How to Ask · 22 Jul 2026 · 29 likes Where I part company with post #45, and it is a narrow parting. Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and…
-
Prescription portability between countries Replied, post #107 · Access › International · 21 Jul 2026 · 7 likes Adding the measurement that post #105 says would settle it. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical…
-
Preservatives: function, testing, and limits — one year on Replied, post #32 · Pharmacology › Formulation chemistry · 16 Jul 2026 · 9 likes A note on scope: what I am saying about Preservatives applies to the case in the first post and I would not extend it further without checking.
-
A critique that turned out to be unfair, retracted by its author Replied, post #31 · Evidence › Study critique · 15 Jul 2026 · 8 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. That is the…
-
eGFR fluctuation and the creatinine denominator problem Replied, post #2 · Clinical › Bloodwork · 15 Jul 2026 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. I would keep egfr fluctuation and the decision it usually gets used for separate…
-
Seven-day rolling means and why weekly readings mislead Replied, post #34 · Outcomes › Progress reports · 15 Jul 2026 · 1 like Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. That is what I would do. It may not…
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #9 · Pharmacology › Receptor biology · 12 Jul 2026 · 0 likes Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response curves flattening at the top is what you would expect from that.…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #107 · Start Here › How to Ask · 7 Jul 2026 · 22 likes Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which.…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #5 · Analytics › Impurities & related substances · 7 Jul 2026 · 3 likes Post #3 answers the question as asked. The question underneath it is different. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #107 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 18 likes Where I have landed on Carryover, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed…
-
Mood changes: monitoring, and when to involve a professional — what changed since Replied, post #11 · Wellbeing › Mental health · 3 Jul 2026 · 1 like Where somebody's motivation for treatment was tied up with appearance, changes can be more complicated than expected, and describing that is not a failure. The…
-
Forced degradation studies: designing one that is informative Replied, post #89 · Analytics › Method validation · 2 Jul 2026 · 0 likes Confirming post #88 from a second method, which matters more than confirming it from a second person. My understanding of forced degradation studies is a few years old…
-
Fasting versus non-fasting and which tests care Replied, post #56 · Clinical › Bloodwork · 25 Jun 2026 · 11 likes What I want from this fasting versus non-fasting thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check…
-
What to include when your question involves a chromatogram — one year on Replied, post #42 · Start Here › How to Ask · 18 Jun 2026 · 1 like Post #40 describes the usual case. This is about the unusual one. It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of…
-
Racemisation and why it is invisible to a mass measurement Replied, post #120 · Analytics › Impurities & related substances · 15 Jun 2026 · 26 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #15 · Documentation › Doc review · 31 May 2026 · 0 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. Nothing in a maintained document is medical advice and the review should confirm the…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #68 · Practice › Administration · 20 May 2026 · 0 likes Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area repeatedly is worth a change of technique or of site rather…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #57 · Compounds › Tirzepatide · 16 May 2026 · 26 likes Taking post #54 at face value and following it one step further. The failure mode on Tirzepatide and nausea is boring rather than dramatic. It is almost always the step…
-
Packaging that arrived damaged: documenting it properly Replied, post #7 · Sourcing › Logistics · 8 May 2026 · 0 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. The confident version of this sentence would be wrong,…
-
Reading U-100 graduations, with a conversion table Replied, post #25 · Devices › Syringes & needles · 3 May 2026 · 13 likes Taking post #22 at face value and following it one step further. What I can speak to on reading U-100 graduations is narrow, so I will keep it narrow rather than…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #134 · Analytics › Mass spectrometry · 2 May 2026 · 17 likes On Charge states: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #68 · Outcomes › Body composition · 1 May 2026 · 0 likes Where I part company with post #66, and it is a narrow parting. DXA on the same machine with the same technician has a least significant change for lean mass of roughly…
-
Revisiting: Absolute versus relative contraindications Replied, post #74 · Safety › Contraindications · 24 Apr 2026 · 0 likes Where a contraindication is relative rather than absolute, the reasoning usually appears in the assessment report rather than the labelling.
-
Amylin receptor signalling and satiety — what changed since Replied, post #64 · Pharmacology › Receptor biology · 18 Apr 2026 · 1 like Answering the question post #62 raises rather than the one it answers. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved…
-
Spike-and-recover accuracy for a peptide assay Replied, post #123 · Analytics › Method validation · 11 Apr 2026 · 24 likes Something worth flagging about spike-and-recover accuracy: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #76 · Sourcing › Regulatory · 8 Apr 2026 · 0 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.
-
What a certificate commits its issuer to — one year on Replied, post #45 · Analytics › COA interpretation · 7 Apr 2026 · 3 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Started this topic · Compounds › Retatrutide · 31 Mar 2026 · 18 likes Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one year on — that is the question, and I have not found it answered plainly anywhere…
-
Sample handling between despatch and injection Replied, post #2 · Analytics › Method validation · 26 Mar 2026 · 3 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #7 · Practice › Administration · 22 Mar 2026 · 1 like Picking up post #4: that is the part I would want checked first. Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #42 · Compounds › Tirzepatide · 12 Mar 2026 · 8 likes Confirming post #39 from a second method, which matters more than confirming it from a second person. 2.5 mg starting dose looks different depending on whether you are…
-
CJC-1295 with and without DAC: what the modification does Replied, post #4 · Compounds › Secretagogues & GH axis · 25 Feb 2026 · 3 likes The opening post describes the usual case. This is about the unusual one. Small correction to my own earlier position on CJC-1295. I had the units the wrong way round,…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #22 · Practice › Reconstitution · 23 Feb 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #44 · Analytics › Mass spectrometry · 13 Feb 2026 · 13 likes Adding the measurement that post #42 says would settle it. The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the analogous expression for higher…
-
Trifluoroacetate content and its consequences Replied, post #75 · Analytics › Impurities & related substances · 3 Feb 2026 · 28 likes This follows post #74 rather than contradicting it. On trifluoroacetate content the community has more anecdote than the confidence in this thread implies, and I…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #17 · Documentation › Wiki requests · 30 Dec 2025 · 0 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important.
-
Batch date after test date, and other internal inconsistencies Replied, post #31 · Analytics › COA interpretation · 27 Dec 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
[2026 update] Long-time reader, first-time poster Replied, post #35 · Lounge › Introductions · 22 Dec 2025 · 8 likes Glad to see another member from outside the usual regions. The access and regional categories are thin for anywhere that is not the UK, EU or North America, and a dated…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #28 · Analytics › Method validation · 21 Dec 2025 · 31 likes Whatever the answer on inter-laboratory comparison turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
-
Pen dose counters: what a click does and does not guarantee Replied, post #41 · Devices › Pens & autoinjectors · 15 Nov 2025 · 10 likes This follows post #38 rather than contradicting it. Needle changes between doses are specified for a reason and the reasons are dose accuracy and sterility rather than…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #16 · Access › Pricing · 14 Nov 2025 · 9 likes Worth separating two things that post #12 runs together. Two claims get bundled together under Price changes and they need separating. The descriptive one — this is…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #33 · Compounds › Semaglutide · 24 Oct 2025 · 32 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #13 · Practice › Storage & stability · 20 Oct 2025 · 7 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #63 · Documentation › Doc review · 25 Sep 2025 · 30 likes A note on how Promotion criteria gets discussed rather than on Promotion criteria itself: the confident posts get the replies and the careful ones get ignored, and the…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #38 · Practice › Storage & stability · 14 Sep 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #48 · Evidence › Study critique · 14 Sep 2025 · 0 likes The arithmetic in post #47 is right; the assumption feeding it is the part to check. Two questions I would want answered before drawing anything from the Reverse…
-
[2026 update] US compounding rules and how they changed Replied, post #37 · Regional › North America · 10 Sep 2025 · 1 like Narrowing post #35, because the general version has more than one answer. Cross-border purchasing raises both a legal question and a practical one, and the legal one is…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #91 · Compounds › Oral incretins · 29 Aug 2025 · 0 likes I read post #87 twice before replying, because I had assumed the opposite. The class is broadening fast enough that anything written here about which orals exist is…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #102 · Clinical › Comorbidities · 27 Aug 2025 · 5 likes Post #101 answers the question as asked. The question underneath it is different. Gastrointestinal conditions interact with a mechanism that slows gastric emptying in…
-
Preparing for an appointment: one page, three questions Replied, post #32 · Clinical › Prescriber conversations · 17 Aug 2025 · 9 likes Narrowing post #31, because the general version has more than one answer. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses…
-
Are there stupid questions here? A staff answer, at length Replied, post #73 · Start Here › Welcome · 14 Aug 2025 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What pooling buys you and what it destroys Replied, post #2 · Evidence › Meta-analyses · 7 Aug 2025 · 4 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. What I would want before treating pooling buys as settled:…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #70 · Access › Insurance & coverage · 6 Aug 2025 · 5 likes No disagreement from me. Posting only so the question does not look ignored.
-
Coming back to: Official shortage notices and what they authorise Replied, post #77 · Access › Shortages · 2 Aug 2025 · 0 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. I would call that likely rather…
-
Coming back to: When "no data" is the complete and final answer Replied, post #62 · Compounds › Other compounds · 28 Jul 2025 · 0 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Sodium, potassium and magnesium when intake drops Replied, post #77 · Nutrition & Training › Hydration & electrolytes · 26 Jul 2025 · 17 likes Answering the question post #74 raises rather than the one it answers. Fluid intake and electrolyte intake are separate questions and drinking more water alone can make…
-
Which panel is worth repeating and which is worth ignoring Replied, post #68 · Clinical › Bloodwork · 24 Jul 2025 · 21 likes Post #66 is right about the mechanism and I think understates the practical bit. Taking panel seriously for a moment rather than deflecting: the honest position is that…
-
Regression to the mean in progress reports Replied, post #35 · Research Methods › Statistics · 20 Jul 2025 · 4 likes The honest answer on regression is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
-
Interpreting a composition change that is within the error bars Replied, post #18 · Outcomes › Body composition · 19 Jul 2025 · 26 likes Post #15 answers the question as asked. The question underneath it is different. Changes during titration: measuring body composition during active titration is less…
-
Antibiotics and a course of something with delayed emptying Replied, post #82 · Practice › Interactions · 5 Jul 2025 · 1 like Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. I would be…
-
What a documentation review can and cannot tell you Replied, post #14 · Sourcing › Independent verification · 24 Jun 2025 · 1 like Filing a mild objection to the consensus on documentation review. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #50 · Evidence › Journal club · 23 Jun 2025 · 33 likes Suggest the next paper at the end of the session rather than by message afterwards. The room has just worked out what it wants to know next. If that is already…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 5 Jun 2025 · 5 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #33 · Devices › Cold chain · 30 May 2025 · 1 like Trying to state the Airline travel position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #9 · Analytics › COA interpretation · 30 May 2025 · 1 like An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #106 · Devices › Cold chain · 19 May 2025 · 29 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
Pregnancy as an absolute contraindication Replied, post #31 · Safety › Contraindications · 18 May 2025 · 32 likes Pregnancy is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Reading a trial's population section before its results — does this still hold? Replied, post #107 · Evidence › Trials · 15 May 2025 · 8 likes Adding thanks rather than a view. I do not have a view worth the space.
-
A well-designed study with a badly written abstract Replied, post #74 · Evidence › Study critique · 11 May 2025 · 1 like The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact. That is…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #36 · Sourcing › Independent verification · 1 May 2025 · 2 likes Post #34 and I disagree about the size of the effect, not about the direction. Speaking only to Janoshik as I have actually seen it, rather than as it is usually…
-
When "no data" is the complete and final answer Replied, post #158 · Compounds › Other compounds · 24 Apr 2025 · 0 likes I had written a reply contradicting post #156 and deleted it. Here is what survived. When "no data" is the complete and final answer: if there is no published human…
-
Deamidation and the close-eluting pair it produces Replied, post #27 · Analytics › Impurities & related substances · 17 Apr 2025 · 4 likes I read post #25 twice before replying, because I had assumed the opposite. Checked the deamidation claim against the primary source this morning. It survives, with a…
-
Albumin binding and how it produces a long half-life Replied, post #22 · Pharmacology › Pharmacokinetics · 7 Apr 2025 · 32 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. The accumulation ratio for weekly dosing with a week-long half-life is around two,…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #4 · Practice › Dosing & titration · 6 Apr 2025 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #88 · Evidence › Journal club · 1 Apr 2025 · 5 likes Confirming post #86 from a second method, which matters more than confirming it from a second person. If someone has run SURMOUNT-1 properly I would rather read that…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #121 · Sourcing › Vendor reports · 18 Mar 2025 · 3 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report. That is all the detail I…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #14 · Practice › Dosing & titration · 14 Mar 2025 · 0 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
Pen wastage and its effect on real cost — the long version Started this topic · Access › Pricing · 7 Mar 2025 · 56 likes Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. A narrow question…
-
Transit times by route, from a logged dataset — the long version Replied, post #60 · Sourcing › Logistics · 15 Feb 2025 · 4 likes Where the Transit times discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Why the Start Here categories exist, and what they are not for — one year on Replied, post #3 · Start Here › Welcome · 27 Jan 2025 · 3 likes The reason Start keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #105 · Evidence › Journal club · 26 Jan 2025 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
[2026 update] New subcategory: rationale and scope Replied, post #104 · Meta › Announcements · 29 Dec 2024 · 2 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
[2026 update] New subcategory: rationale and scope Replied, post #78 · Meta › Announcements · 19 Dec 2024 · 18 likes Post #76 and I disagree about the size of the effect, not about the direction. Thank you for announcing it in advance rather than after. The number of places that do…
-
EMA product information as a primary source — does this still hold? Replied, post #125 · Regional › European Union · 18 Nov 2024 · 0 likes Post #124 is right about the mechanism and I think understates the practical bit. Reimbursement is decided nationally and varies substantially between member states for…
-
Transporting a vial for a weekend away Replied, post #32 · Practice › Storage & stability · 5 Nov 2024 · 23 likes Light protection is easy and cheap. The original carton exists for a reason and a vial stored in it is protected without anybody having to think about it again.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #137 · Nutrition & Training › Hydration & electrolytes · 6 Oct 2024 · 8 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #60 · Analytics › COA interpretation · 20 Sep 2024 · 6 likes Post #56 and I disagree about the size of the effect, not about the direction. A definition problem is doing most of the work in this field-by-field walk through a…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #7 · Devices › Syringes & needles · 7 Jul 2024 · 13 likes Answering the question post #3 raises rather than the one it answers. Offering a way to settle Dead volume across syringe rather than another opinion about it. Two…
-
Assessing a warm arrival: the decision process — one year on Replied, post #89 · Sourcing › Logistics · 1 Jun 2024 · 0 likes Answering the question post #87 raises rather than the one it answers. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance…